Synthetic High-Density Lipoprotein-Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma

Immunotherapies have shed light on the treatment of many cancers, but have not improved the outcomes of glioma (GBM). Here, we demonstrated that suppressor of cytokine signaling 1 (SOCS1) was associated with the GBM-associated immunosuppression and developed a multifunctional nanomedicine, which silenced SOCS1 in the tumor microenvironment (TME) of GBM and triggered strong antitumor immunity against GBM. Synthetic high-density lipoprotein (sHDL) was selected as the nanocarrier and a peptide was used to facilitate the blood-brain-barrier (BBB) penetration. The nanocarrier was loaded with a small interfering RNA (siRNA), a peptide, and an adjuvant to trigger antitumor immunity. The nanomedicine concentrated on the TME in vivo, further promoting dendritic cell maturation and T cell proliferation, triggering strong cytotoxic T lymphocyte responses, and inhibiting tumor growth. Our work provides an alternative strategy to simultaneously target and modulate the TME in GBM patients and points to an avenue for enhancing the efficacy of immunotherapeutics.     

New bioactive pyrrospirones C−I from a marine-derived fungus Penicillium sp. ZZ380

Seven rare pyrrospirones C?I (1–7) as well as 18 known compounds were isolated from a marine-derived fungus Penicillium sp. ZZ380. Structures of the new pyrrospirones were elucidated by extensive NMR spectroscopic analyses, HRESIMS data, and Mosher's method. Pyrrospirone D (2) was also confirmed by X-ray diffraction analysis. Pyrrospirone G (5) showed potent activity in inhibiting the proliferation of different glioma cells with IC₅₀ values of 1.06–8.52 μM and pyrrospirones C (1), F (4), and I (7) had antimicrobial activity against the growth of both methicillin-resistant Staphylococcus aureus and Escherichia coli with MIC values of 2.0–5.0 μg/mL.     

傅里叶变换中红外光谱法检测脑胶质瘤

采用傅里叶变换衰减全反射中红外光谱法检测了19例液氮冻存的脑胶质瘤离体组织样品(星形细胞瘤10例, 少枝-星形细胞瘤9例), 对得到的红外光谱进行分析发现, 恶性程度不同的星形细胞瘤组织的红外光谱存在差异, 并且不同类型的脑胶质瘤组织的红外光谱也表现出较为明显的区别, 因此可以根据各个特征吸收峰的峰位、 峰形及谱峰强度等信息来区分脑胶质瘤, 并初步鉴别脑胶质瘤的性质. 研究结果表明, 通过某些特征吸收峰峰位的变化来鉴别星形细胞瘤和少枝-星形细胞瘤与病理诊断结果的符合率约为80%, 说明傅里叶变换衰减全反射中红外光谱法有望发展成为一种对样品无损伤、 快速的脑肿瘤诊断新方法.     

Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging

Dynamic contrast-enhanced magnetic resonance imaging (MRI) is widely used for measuring perfusion and blood volume, especially cerebral blood volume (CBV). In case of blood-brain barrier (BBB) disruption, the conventional techniques only partially determine the pharmacokinetic parameters of contrast medium (CM) exchange between different compartments. Here a modified pharmacokinetic model is applied, which is based on the bidirectional CM exchange between blood and two interstitial compartments in terms of the fractional volumes of the compartments and the vessel permeabilities between them. The evaluation technique using this model allows one to quantify the fractional volumes of the different compartments (blood, cells, slowly and fast enhancing interstitium) as well as the vessel permeabilities and cerebral blood flow (CBF) with a single T1-weighted dynamic MRI measurement. The method has been successfully applied in 25 glioma patients for generating maps of all of these parameters. The fractional volume maps allow for the differentiation of glioma vascularization types. The maps show a good correlation with the histological grading of these tumors. Furthermore, regions with enhanced interstitial volumes are found in high-grade gliomas. Differences in permeability maps of Gd-DTPA apart from BBB disruption do not exist between different tissue types. CBF measured in high-grade glioma is less pronounced than it would be expected from their blood volume. Therefore pharmacokinetic imaging provides an additional tool for glioma characterization.     

Application value of a new Co(II) complex in treatment of glioma by inducing glioma cell apoptosis

When a 3,5-bis(3,5-dicarboxylphenoxy)benzoic acid (H₅L) ligand reacted with Co(II) salt as well as the 4′-bis(benzoimidazo-1-ly)biphenyl) (4,4′-bbibp) ligand, a novel coordination polymer based on Co with the chemical composition of {[Co₂(HL) (4,4′-bbibp)₂]·4(H₂O)}_n has been created. The single crystal X-ray diffraction and elemental analysis of compound 1 were carried out and the data were recorded. Its application value on the glioma was evaluated with the CCK-8 assay and the Annexin V-FITC/PI apoptosis assay. It has been shown that carboxyl groups in Co complexes can form multiple binding interactions with target proteins, however, the imidazole group doesn't form any binding interaction.     

嗜神经病毒衍生肽RVG29介导的靶向纳米载药胶束的合成及抗肿瘤活性

将羧基化的水溶性葡聚糖(Dex)与紫杉醇(PTX)化学偶联, 制得载药纳米胶束M(PTX), 再将M(PTX)与嗜神经性病毒衍生肽(RVG29)化学偶联, 得到RVG29靶向的载药纳米胶束M(RVG,PTX). 采用核磁共振氢谱(¹H NMR)测定了Dex-PTX及RVG-Dex-PTX键合物的分子量, 并对2种胶束进行了表征, 考察了2种胶束对肿瘤细胞的抑制效果及细胞凋亡情况, 观察了C₆细胞对荧光标记M(RVG,PTX)和M(PTX)的摄取情况. 结果表明, 羧基化葡聚糖-紫杉醇键合物的分子量约为16500, 紫杉醇的质量约为葡聚糖的20%, RVG29的质量约为葡聚糖的10%. 2种胶束的粒径在45~60 nm之间; M(RVG,PTX)胶束对C₆细胞的抑制作用具有浓度和时间依赖性, 细胞抑制率随着作用时间和药物浓度增加而增加, 且M(RVG,PTX)胶束对C₆细胞的抑制作用强于M(PTX)胶束. 细胞摄取实验结果表明, 与M(PTX)相比, C₆细胞摄取了更多的M(RVG,PTX)胶束. 如果先用游离的RVG29处理C₆细胞, 再进行细胞实验, 则M(RVG,PTX)胶束对C₆细胞生长的抑制作用及被C₆细胞摄取的比率显著降低, 与 M(PTX)相当. 表明靶向载药胶束M(RVG,PTX)中的RVG29保留了游离RVG29的活性, 对C₆细胞依然具有靶向效应, 从而介导了M(RVG,PTX)被C₆细胞的摄取, 增强了对C₆细胞的生长抑制作用. 由于M(RVG,PTX)胶束只使用水溶性葡聚糖作载体, 不涉及疏水高分子链段, 不需要分别制备载药高分子和靶向高分子然后再共组装, 因而制备过程比较简单, 同时具有载药和靶向功能.     

Combination of sonodynamic with temozolomide inhibits C6 glioma migration and promotes mitochondrial pathway apoptosis via suppressing NHE-1 expression

Temozolomide (TMZ) was used for clinical postoperative or non-surgical chemotherapy patients. However, its effect remains unsatisfactory and gradually discovered that the presence of chemoresistance. To explore more effective therapy using TMZ, we investigate the effects of combination of application of TMZ together with Sonodynamic therapy (SDT), which is based on the ultrasonic activation of a sonosensitizer, with low toxicity, noninvasive, deeper penetrability and a promising approach for treating malignant glioma by inducing apoptosis on glioma cells in vitro. Sodium–hydrogen exchanger isoform 1 (NHE1), which enable glioblastoma cells to escape TMZ-mediated toxicity via increased H⁺ extrusion and affect the apoptosis effect on C6 glioma cells in vitro. The C6 cells survival rate and time point of TMZ resistance were tested by the Cell Counting Kit-8 (CCK8) viability assay. Western blot analysis results showed that the expression of NHE1 and matrix metalloproteinase-2 (MMP-2) protein obviously decreased by TMZ + SDT. Meanwhile, combined treatments enhanced the expression of mitochondrial pathway apoptosis proteins, as well as suppressed MMP-2 to weaken the migration ability in TMZ-resistant C6 cell line. These results provided the first evidence that the sensitivity of TMZ chemotherapy in resistant malignant glioma may be improved by SDT.     

溴酚蓝对大鼠脑胶质瘤模型的染色作用

目的研究溴酚蓝对大鼠胶质瘤模型的染色作用,为手术精确切除人脑胶质瘤提供实验基础。方法建立Fischer 344大鼠胶质瘤模型,MRI检查证实。静脉注射不同剂量（30～360mg/kg）溴酚蓝,15min后处死取脑,检查溴酚蓝对脑肿瘤的染色情况;并注射相同剂量（180mg/kg）的溴酚蓝,在不同时间处死取脑,检查溴酚蓝对脑肿瘤的染色情况。对无瘤实验大鼠注射不同剂量溴酚蓝,观察其毒性反应。结果溴酚蓝对大鼠胶质瘤有明显的染色作用,其染色与周围脑组织有清晰的界限,染色时间出现在注射后10min～6h。30d未观察到溴酚蓝的任何毒性反应。结论溴酚蓝在不同时间点能够清晰染色大鼠胶质瘤,有可能作为人脑胶质瘤的术中染色剂来区别肿瘤组织和正常脑组织。